Mineralys Therapeutics Ownership & Insider Activity

Mineralys Therapeutics (MLYS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.0% of shares outstanding. Institutional investors hold 46.0%. Over the past 90 days, insiders made 3 sales worth $2.7M.

Shares Outstanding

88.407M

Shares Float

73.847M

Insider Shares Owned

875.343K

Insider % Owned

1.0%

Institutional Shares Held

40.677M

Institutional % Held

46.0%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$2.7M total

Net Activity

Net Selling

Net Value (90d)

-$2.7M

Mineralys Therapeutics Insider Transactions (Last 6 Months)

모든 내부자 거래 내역 보기 →

Date	Insider	Title	Type	Shares	Price	Value
Sep 21, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$20.68	$111K
Sep 15, 2026	Daphne Karydas	DIRECTOR	SELL-OPTIONS	—	$20.30	$50K
Aug 21, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$19.61	$95K
Aug 10, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$21.55	$24K
Jul 21, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$20.06	$101K
Jul 17, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$20.98	$5K
Jul 13, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	10.700K	$27.24	$291K
Jul 13, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.349K	$17.28	$454K
Jul 9, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$23.15	$31K
Jun 30, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	75.000K	$26.14	$2.0M
Jun 26, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$19.57	$1.3M
Jun 17, 2026	Daphne Karydas	DIRECTOR	SELL-OPTIONS	—	$18.51	$39K
Jun 15, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.348K	$18.37	$248K
Jun 10, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$14.54	$165K
May 18, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$21.50	$5K
May 11, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.349K	$18.68	$516K
Apr 17, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$23.38	$7K
Apr 13, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.348K	$17.08	$446K
Apr 13, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	15.730K	$26.83	$422K
Apr 9, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$21.69	$25K
Mar 31, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	75.000K	$26.27	$2.0M
Mar 31, 2026	Daphne Karydas	DIRECTOR	SELL-OPTIONS	—	$18.51	$39K
Mar 27, 2026	RA CAPITAL MANAGEMENT LP, RA Capital Healthcare Fund LP, RA Capital Nexus Fund III LP, Peter Kolchinsky, Rajeev Shah	DIRECTOR	BUY	369.000K	$23.75	$8.8M

More with Benzinga EdgeGet Access

Mineralys Therapeutics Inc

Mineralys Therapeutics Ownership & Insider Activity

Mineralys Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

뉴스

파트너 / 기고자

벤징가 글로벌

People Also Watch